“…Sheil and colleagues 9 showed that kidney transplant recipients with cancer had better 8‐year survival after transplantation than those without cancer, although after that period, survival of recipients with cancer worsens rapidly compared to recipients without cancer. The declining survival was due to cancer or allograft rejection after withdrawal of immunosuppressive therapy to control malignancy.…”
Longer early to mid-term allograft and overall survival was seen in patients with NMSC, but long-term survival rates must be examined to determine whether mortality rates increase later for patients with NMSC, as noted in previous studies.
“…Sheil and colleagues 9 showed that kidney transplant recipients with cancer had better 8‐year survival after transplantation than those without cancer, although after that period, survival of recipients with cancer worsens rapidly compared to recipients without cancer. The declining survival was due to cancer or allograft rejection after withdrawal of immunosuppressive therapy to control malignancy.…”
Longer early to mid-term allograft and overall survival was seen in patients with NMSC, but long-term survival rates must be examined to determine whether mortality rates increase later for patients with NMSC, as noted in previous studies.
“…For those who survive all the early dangers and are otherwise doing well, however, cancer becomes a cruel threat as years go by-for example, in one report cancer accounted for a third of deaths which occurred beyond five years after transplantation. 22 Those transplant recipients treated with standard immunosuppressive agents seem certain to continue to be at risk of developing cancer. In whatever way the complex aetiological factors interrelate the cancers seem to be consequent on an induced immune deficiency syndrome.…”
“…Between August 1967 and May 1973 349 cadaveric renal transplant operations were carried out on 325 recipients at Sydney Hospital and the Royal Prince Alfred Hospital (Sheil et al, 1972(Sheil et al, , 1973. The total follow-up experience to May 1973 was 570 patient years, during which time there were 100 deaths.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.